VITA Group have been hurt by rumours of a Telstra buy back of its high performing stores which sent its share price sharply downwards.
ERM Power took a 226 per cent hit to its profits although it has forecast a return to solid margins.
And both Impedimed and Capilano Honey have been spending money on research and development, with the end game for each likely to see a turnaround in their performances.
CLICK BELOW FOR THIS YEAR'S TOP 50
Get our daily business news
Sign up to our free email news updates.